Novavax Inc. buy BTIG Research
Start price
28.02.25
/
50%
€6.81
Target price
28.02.26
€18.25
Performance (%)
22.38%
End price
01.03.26
€8.34
Summary
This prediction ended on 01.03.26 with a price of €8.34. The prediction had a final performance of 22.38%. BTIG_Research has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Buy. BTIG_Research has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Novavax Inc. | -2.776% | -2.776% | 19.148% |
| iShares Core DAX® | -0.681% | -4.853% | 1.940% |
| iShares Nasdaq 100 | -0.033% | 2.862% | 18.901% |
| iShares Nikkei 225® | -0.536% | -5.024% | 28.152% |
| iShares S&P 500 | -0.211% | 0.925% | 13.685% |
Comments by BTIG_Research for this prediction
In the thread Novavax Inc. diskutieren
Novavax, Inc. (NASDAQ: NVAX) is now covered by analysts at BTIG Research. They set a "buy" rating and a $19.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat
In the thread Trading Novavax Inc.
Die von BTIG_Research gewählte maximale Laufzeit wurde überschritten